November 2010 Issue of MMM
The chilly morning commutes into the office, and the dark journeys home, are evidence enough that fall has set in. But it's not only the ...
Pharmas aren't merely downsizing reps, they're rethinking the detail and installing specialized sales forces, breaking them up into regions and making outcomes king, Matthew Arnold ...
Academic medical centers are examining whether commercial support for CME should be allowed to continue and how to prevent bias if it does. As consensus ...
The seventh annual MM&M Awards gala presentation took place October 12 in a new venue
Dr. Martin Samuels says the idea for Lighthouse Learning, a newly launched CME provider that eschews industry money and won't conduct meetings or solicit exhibitors, ...
Continuing industry consolidation, higher-risk decision-making with riskier pipelines, and pressure to succeed in your position amidst job cuts--yet there's still demand for strategic, primary market ...
There is an ongoing revolution occurring in the treatment of cancer. Unfortunately, it is easy for the public to miss the growing excitement for the ...
Pfizer's $3.6 billion acquisition of King Pharmaceuticals will expand Pfizer's portfolio in the pain category, adding Embeda, Avinza and the Flector Patch to Pfizer's Lyrica ...
Proctor & Gamble and Somaxon Pharmaceuticals have deployed 215 reps in support of Silenor, a newly approved sleep aid indicated for sleep maintenance. E-detailing programs ...
Sanofi-Aventis will winnow its US sales forces down by 1,400, the company announced.
Featuring news about Janssen, Caeylx/Doxil, Salesforce.com, Veeva Systems, Physicians Interactive, OptimizerRx and SampleMD
Med Ed Report
Medical Exchange is assembling one CME meeting that addresses three audiences over six days: specialists, primary care doctors and patients.
As criticism over commercial support for CME continues, a national recommendation on the funding issue is imminent from the Conjoint Committee on CME (CCCME).
All three gubernatorial candidates see defects in Massachusetts' gift ban, notes a State House News Service report outlining the views of Democrat Deval Patrick, Republican ...
Featuring news about Skyscape and the Massachusetts Medical Society, Institute for Healthcare Improvement, VHA, the ACCME, the Accreditation Council for Pharmacy Education, the American Nurses ...
Elsevier launched the International Journal of Surgery Case Reports (IJSCR), a new online journal dedicated exclusively to case reports.
A year after purchasing WebMD's The Little Blue Book, a referral directory for docs, mdHub changed its name to HCPlexus, and expanded its offerings to ...
Featuring news about Elsevier, UBM Medica, MediSpecialty.com, Wiley-Blackwell and The Royal College of Speech and Language Therapists
Journal ad revenues took an unforeseen turn for the better in the first half of the year, with overall ad spend jumping 14.3% from January ...
AstraZeneca has launched a professional site for its Vimovo arthritis drug that features a live chat option.
Consumers looking for diabetes information online respond to different tools and website functionality than, say, people looking for information on cancer or heart disease, a ...
Featuring news about HealthiNation, Novartis, VakTrak and the Interactive Advertising Bureau
AstraZeneca has proven repeatedly that DTC drives business. They were among the earliest innovators with their DTC launch for Prilosec more than 10 years ago.
Sanofi-Aventis launched a Lantus-branded "diabetes awareness campaign" featuring Paul and Mira Sorvino.
Takeda ran newspaper ads urging readers to switch to its Actos from rival Avandia after the GlaxoSmithKline drug was hit with FDA marketing restrictions due ...
Pfizer and Lilly shared their schedules for Viagra and Cialis ED ads with the Parents Television Council, which published them on its website so that ...
KnowledgePoint360 has acquired TGaS Advisors, provider of data and advice to pharma sales and marketing organizations.
Johnson & Johnson said it's returning some versions of children's and infant's Tylenol to stores after recalling millions of bottles earlier this year.
John Cahill, previously president of McCann Healthcare EMEA and Asia-Pacific as well as medical education, becomes worldwide CEO of the network.
InVentiv is merging Irvine, CA-based medical advertising shop Ignite Health with Manhattan-based Y Brand, a healthcare branding and strategy firm.
Featuring news about Zeno Group, Draftfcb Health London and Compass Healthcare Marketers
FDA's traditional internal secrecy cracked ever-so-slightly open in September, when it announced its long-awaited decision on the uncertain risks of GlaxoSmithKline's plummeting blockbuster, Avandia, for ...
As new resources come into FDA's Division of Drug Marketing, Advertising and Commissions, it reports that it has exceeded last year's totals for issuing warning ...
Yielding to industry objections, FDA has abandoned its proposed definition for a suspected adverse drug reaction (SADR) in its just-finalized rule on clinical trial safety ...
Clinical research is the foundation for the practice of evidence-based medicine. It is used to determine whether new drugs and treatments are safe and effective. ...
One definition of social media is public conversation between private individuals.
Advocacy organizations serve as primary drivers of opinion and knowledge with patients, media and policy makers.
- McCann Health forms new global consultancy
- Alexion uses superheroes, social media to raise rare-disease awareness
- Five things for pharma marketers to know: Tuesday, September 20, 2016
- Five things for pharma marketers to know: Wednesday, September 21, 2016
- Five things for pharma marketers to know: Monday, September 19, 2016
- Merck educates doctors about biosimilars, long before it will sell one in the U.S.
- 4 trends with the potential to change behavior in the patient journey
- When it comes to professional ads, print makes its comeback
- 2016 Pharma Report: All the data in one place
- What do physicians think about biosimilars?
- The FDA approves Amgen's biosimilar version of Humira
- Five things for pharma marketers to know: Friday, September 23, 2016
- Five things for pharma marketers to know: Thursday, September 22, 2016
- Drug Pricing Will Be a Key Issue, Whether Clinton or Trump Win the Election
- The Michael J. Fox Foundation uses Facebook to recruit Ashkenazi Jews for Parkinson's study